# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020467
Filing Date
2024-05-06
Accepted
2024-05-06 08:06:23
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lyel-20240331.htm iXBRL | 10-Q | 1203167
2 | EX-31.1 | lyel-20240331x10qxexx311.htm | EX-31.1 | 10646
3 | EX-31.2 | lyel-20240331x10qxexx312.htm | EX-31.2 | 10616
4 | EX-32.1 | lyel-20240331x10qxexx321.htm | EX-32.1 | 7489
10 |  | lyel-20240331_g1.jpg | GRAPHIC | 158306
| Complete submission text file | 0001628280-24-020467.txt |  | 6554073

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lyel-20240331.xsd | EX-101.SCH | 42634
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lyel-20240331_cal.xml | EX-101.CAL | 52312
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lyel-20240331_def.xml | EX-101.DEF | 215447
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lyel-20240331_lab.xml | EX-101.LAB | 587956
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lyel-20240331_pre.xml | EX-101.PRE | 411223
69 | EXTRACTED XBRL INSTANCE DOCUMENT | lyel-20240331_htm.xml | XML | 755214

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 24915647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)